Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Recurrent C. Difficile Infection”

44 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 44 results

Large-scale testing (Phase 3)Ended earlyNCT02395848
What this trial is testing

Efficacy of 30-day Duration of Fidaxomicin for Recurrent C. Difficile Infection

Who this might be right for
Clostridium Difficile Infection
McMaster University 31
Not applicableStudy completedNCT06669936
What this trial is testing

Rescue FMT with Bezlotoxumab for Recurrent C. Difficile Infection

Who this might be right for
Recurrent C. Difficile Infection
Alexander Khoruts 24
Not applicableLooking for participantsNCT07250724
What this trial is testing

C. Difficile Toxin Levels in Stool From Healthy Individuals Following Standard of Care Antibiotic Treatment for CDI.

Who this might be right for
Clostridioides Difficile Infection Recurrence
Bactolife A/S 60
Testing effectiveness (Phase 2)Study completedNCT02299570
What this trial is testing

Microbiota Restoration Therapy for Recurrent Clostridium Difficile Infection

Who this might be right for
Enterocolitis Clostridium Difficile Recurrent
Rebiotix Inc. 150
Large-scale testing (Phase 3)Looking for participantsNCT05330182
What this trial is testing

LMN-201 for Prevention of C. Difficile Infection Recurrence

Who this might be right for
Clostridioides Difficile Infection
Lumen Bioscience, Inc. 375
Testing effectiveness (Phase 2)Ended earlyNCT02255305
What this trial is testing

FMT Versus Antimicrobials for Initial Treatment of Recurrent CDI

Who this might be right for
Clostridium Difficile Infection
Endeavor Health 6
Testing effectiveness (Phase 2)Looking for participantsNCT07285213
What this trial is testing

Prevention of Recurrent C. Difficile Infection Study With AZD5148 Monoclonal Antibody

Who this might be right for
Clostridioides Difficile Infection
AstraZeneca 230
Post-approval studies (Phase 4)Study completedNCT03466502
What this trial is testing

Oral Vancomycin to Prevent Recurrent C Difficile Infection With Antibiotics

Who this might be right for
Clostridium Difficile Infection
University of Nevada, Reno 104
Testing effectiveness (Phase 2)Ended earlyNCT03617445
What this trial is testing

Fecal Microbiota Transplantation for C. Difficile Infection in Solid Organ Transplant Recipients

Who this might be right for
Clostridium Difficile Infection Recurrence
University of Wisconsin, Madison 3
Not applicableUnknownNCT04187430
What this trial is testing

Validation of a Prediction Score for Recurrent C. Difficile Infection: Implementation for Treatment Algorithm Strategies

Who this might be right for
Clostridium Difficile Infection
Emilio Bouza 513
Large-scale testing (Phase 3)Looking for participantsNCT06979609
What this trial is testing

Secondary Prevention of Clostridioides Difficile Using Vancomycin

Who this might be right for
Clostridioides Difficile InfectionClostridioides Difficile Infection RecurrenceClostridoides Difficile Associated Disease
McGill University Health Centre/Research Institute of the McGill University Health Centre 300
Testing effectiveness (Phase 2)UnknownNCT02557685
What this trial is testing

Gut Microbiota Changes After Fecal Microbiota Transplantation

Who this might be right for
Clostridium Difficile Infection
The Miriam Hospital 6
Large-scale testing (Phase 3)Study completedNCT05831189
What this trial is testing

A Multi-center, Single-arm Trial Exploring the Safety and Clinical Effectiveness of RBX2660 Administered by Colonoscopy to Adults With Recurrent Clostridioides Difficile Infection

Who this might be right for
Clostridium Difficile Infection Recurrence
Ferring Pharmaceuticals 41
Testing effectiveness (Phase 2)Study completedNCT03497806
What this trial is testing

Open-Label Extension of CP101 Trials Evaluating Oral Full-Spectrum Microbiota™ (CP101) in Subjects With Recurrence of Clostridium Difficile Infection

Who this might be right for
Clostridium Difficile InfectionRecurrent Clostridium Difficile InfectionC. Diff+8 more
Finch Research and Development LLC. 132
Testing effectiveness (Phase 2)Study completedNCT03110133
What this trial is testing

Efficacy, Safety, and Tolerability Study of Oral Full-Spectrum MicrobiotaTM (CP101) in Subjects With Recurrent C. Diff

Who this might be right for
Clostridium Difficile Infection Recurrence
Finch Research and Development LLC. 206
Testing effectiveness (Phase 2)Study completedNCT03788434
What this trial is testing

Phase 2 Study of VE303 for Prevention of Recurrent Clostridioides Difficile Infection

Who this might be right for
Clostridium Difficile Infection RecurrenceClostridium Difficile InfectionClostridium Difficile+4 more
Vedanta Biosciences, Inc. 79
Testing effectiveness (Phase 2)Study completedNCT01925417
What this trial is testing

Microbiota Restoration Therapy for Recurrent Clostridium Difficile-associated Diarrhea

Who this might be right for
Recurrent Clostridium Difficile Infection
Rebiotix Inc. 34
Large-scale testing (Phase 3)Study completedNCT02254811
What this trial is testing

FMT Delivered by Capsule Versus Colonoscopy for Recurrent C. Diff

Who this might be right for
Enterocolitis Clostridium Difficile Recurrent
University of Alberta 116
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06948461
What this trial is testing

A Flexible Clinical Trial to Test if Freeze-dried Fecal Microbiota Therapy Helps Treat Diarrhea-predominant Irritable Bowel Syndrome or Prevent Recurring C. Difficile Infections.

Who this might be right for
Irritable Bowel Syndrome, Diarrhea-Predominant (IBS-D)Recurrent Clostridioides Difficile Infection (rCDI)Fecal Microbiota Therapy (FMT)+2 more
PharmaPlanter Technologies Inc 63
Early research (Phase 1)Study completedNCT02830542
What this trial is testing

SER-262 Versus Placebo in Adults With Primary Clostridium Difficile Infection to Prevent Recurrence

Who this might be right for
Clostridium Difficile Infection
Seres Therapeutics, Inc. 96
Load More Results